Showing results (111-120 of 166) with videos related to
Sort By:
Pageof 17
JAMA|October 3, 1986
Effects of exposure to factor concentrates containing donations from identified AIDS patients. A matched cohort studyJ Jason, R C Holman, G Dixon, et al.Clinical Physiology and Biochemistry|January 1, 1993
Retroviral interference with neuronotrophic signaling in human motor neuron disease?M E Westarp, K P Westphal, J Clausen, et al.The Journal of Infectious Diseases|October 1, 1990
Use of paper-absorbed fingerstick blood samples for studies of antibody to human immunodeficiency virus type 1 in intravenous drug usersK A Steger, D E Craven, B F Shea, et al.Urology|March 8, 2013
A prospective study of transition from laparoscopic to robot-assisted radical prostatectomy: quality of life outcomes after 36-month follow-upViktor Berge, Rolf E Berg, Jon R Hoff, et al.JAMA|December 25, 1991
Clinical utility of HIV-IgA immunoblot assay in the early diagnosis of perinatal HIV infectionS Landesman, B Weiblen, H Mendez, et al.The American Journal of Tropical Medicine and Hygiene|November 1, 1978
Trypanosoma cruzi infection in dogs and cats and household seroreactivity to T. cruzi in a rural community in northeast BrazilK E Mott, E A Mota, I Sherlock, et al.The American Journal of Tropical Medicine and Hygiene|November 1, 1979
Epidemiologic studies among Amerindian populations of Amazonia. II. Prepvalence of Mansonella ozzardiD N Lawrence, B Erdtmann, J W Peet, et al.Antimicrobial Agents and Chemotherapy|April 4, 2012
Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosisEmily R Driver, Gavin J Ryan, Donald R Hoff, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|November 1, 1989
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trialM A Kass, M O Gordon, M R Hoff, et al.Journal of Glaucoma|November 19, 2009
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial (1)M A Kass, M O Gordon, M R Hoff, et al.Pageof 17